Prudential Financial Inc. lowered its stake in shares of Silicon Laboratories Inc. (NASDAQ:SLAB - Free Report) by 71.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 3,073 shares of the semiconductor company's stock after selling 7,692 shares during the quarter. Prudential Financial Inc.'s holdings in Silicon Laboratories were worth $382,000 at the end of the most recent quarter.
Several other institutional investors have also recently added to or reduced their stakes in SLAB. Raymond James Financial Inc. purchased a new stake in shares of Silicon Laboratories in the fourth quarter valued at about $14,252,000. Vanguard Group Inc. lifted its position in Silicon Laboratories by 1.9% in the fourth quarter. Vanguard Group Inc. now owns 3,959,580 shares of the semiconductor company's stock valued at $491,859,000 after purchasing an additional 71,942 shares during the period. Fisher Asset Management LLC boosted its holdings in Silicon Laboratories by 114.4% in the 4th quarter. Fisher Asset Management LLC now owns 119,292 shares of the semiconductor company's stock valued at $14,818,000 after purchasing an additional 63,652 shares in the last quarter. GW&K Investment Management LLC increased its position in Silicon Laboratories by 5.6% during the 4th quarter. GW&K Investment Management LLC now owns 682,045 shares of the semiconductor company's stock worth $84,723,000 after purchasing an additional 36,330 shares during the period. Finally, American Century Companies Inc. raised its stake in shares of Silicon Laboratories by 9.2% during the 4th quarter. American Century Companies Inc. now owns 343,131 shares of the semiconductor company's stock worth $42,624,000 after buying an additional 28,867 shares in the last quarter.
Analysts Set New Price Targets
SLAB has been the topic of a number of recent analyst reports. Barclays upped their price objective on Silicon Laboratories from $75.00 to $120.00 and gave the stock an "equal weight" rating in a report on Friday, January 17th. Stifel Nicolaus increased their price target on shares of Silicon Laboratories from $135.00 to $145.00 and gave the company a "buy" rating in a report on Monday, January 6th. Needham & Company LLC reissued a "buy" rating and set a $150.00 price objective on shares of Silicon Laboratories in a report on Wednesday, March 12th. StockNews.com cut shares of Silicon Laboratories from a "hold" rating to a "sell" rating in a report on Thursday, March 27th. Finally, Benchmark reissued a "buy" rating and set a $160.00 price target on shares of Silicon Laboratories in a research note on Wednesday, March 12th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and six have assigned a buy rating to the stock. Based on data from MarketBeat, the company has an average rating of "Hold" and an average target price of $136.20.
Read Our Latest Research Report on Silicon Laboratories
Insider Transactions at Silicon Laboratories
In other news, Director William G. Bock sold 1,000 shares of the company's stock in a transaction dated Tuesday, February 18th. The shares were sold at an average price of $149.43, for a total transaction of $149,430.00. Following the completion of the transaction, the director now owns 31,115 shares of the company's stock, valued at $4,649,514.45. This represents a 3.11 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Navdeep S. Sooch sold 2,360 shares of the firm's stock in a transaction that occurred on Wednesday, February 5th. The stock was sold at an average price of $149.00, for a total transaction of $351,640.00. Following the completion of the sale, the director now directly owns 400,567 shares in the company, valued at $59,684,483. This represents a 0.59 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 5,360 shares of company stock worth $782,610 over the last quarter. 1.60% of the stock is currently owned by insiders.
Silicon Laboratories Stock Performance
SLAB stock traded down $0.33 during trading on Tuesday, hitting $90.97. The stock had a trading volume of 30,755 shares, compared to its average volume of 330,583. The stock has a market cap of $2.95 billion, a price-to-earnings ratio of -15.32 and a beta of 1.33. The company's 50 day moving average price is $126.42 and its two-hundred day moving average price is $122.32. Silicon Laboratories Inc. has a 1-year low of $82.82 and a 1-year high of $160.00.
Silicon Laboratories (NASDAQ:SLAB - Get Free Report) last posted its quarterly earnings data on Tuesday, February 4th. The semiconductor company reported ($0.11) earnings per share for the quarter, meeting analysts' consensus estimates of ($0.11). The business had revenue of $166.25 million during the quarter, compared to analyst estimates of $166.09 million. Silicon Laboratories had a negative net margin of 32.69% and a negative return on equity of 10.46%. The company's revenue was up 91.4% on a year-over-year basis. During the same quarter in the previous year, the business posted ($1.19) earnings per share. As a group, sell-side analysts forecast that Silicon Laboratories Inc. will post -0.97 earnings per share for the current fiscal year.
Silicon Laboratories Profile
(
Free Report)
Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.
Read More

Before you consider Silicon Laboratories, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Silicon Laboratories wasn't on the list.
While Silicon Laboratories currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report